Penumbra Receives FDA Clearance for RED 62 Reperfusion Catheter, Enabling Physicians to …

ALAMEDA, Calif.–(BUSINESS WIRE)–Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced …

Continue

Do you trust this headline?

Based on recent headline ratings, 57% of this readership currently trusts the local media, which has an average score of 85% regionally and is currently trending negative.

57%

Media Trust Score57%

Read All

In

News